"To determine the uptake of noninvasive multitarget stool DNA (mt-sDNA) in a cohort of colorectal cancer (CRC) screening non-compliant average-risk Medicare patients."
The availability of mt-sDNA colorectal cancer screening provided significant medical benefit to Medicare patients cared for in a large multi-specialty group practice who were previously screening-noncompliant1
—Prince M, Lester L, Chiniwala R and Berger B1
REFERENCES 1. Prince M, Lester L, Chiniwala R, Berger B. Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients. World Journal of Gastroenterology. 2017;23(3):464-471. doi:10.3748/wjg.v23.i3.464.